Navigation Links
VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
Date:10/3/2007

SAN JOSE, Calif., Oct. 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced that it presented at the William Blair & Company Small-Cap Growth Stock Conference at 10:00 a.m. ET on October 3, 2007, at the New York Palace Hotel in New York, New York.

An archive of the VNUS presentation webcast is available on the corporate website at http://ir.vnus.com/medialist.cfm. The management speaker was President and Chief Executive Officer Brian Farley.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of symptomatic varicose veins. VNUS sells the VNUS Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate website at http://www.vnus.com.


'/>"/>
SOURCE VNUS Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...he Board of Directors of Dabur India Ltd (DIL) met...lts of the company for the quarter and the full ye... one of Indias leading FMCG Companies. Building on...for over 120 years, Dabur today is Indias most tru...
...ome might squirm at the thought that doctors could...h stories are rampant in many developing countries...ecently a study showed repeated visits by represen...eutical firms resulted in prescription of untested...
...ealth authorities in the US are worried about yet ...squito-spread infection. Rudy Bueno, the Chief ...that the situation may worsen if people don't foll...s still a large percentage of people in Houston wh...
...oncern over side effects of various drugs could be...h profile recalls like Vioxx, the osteoarthritis ...ise Boston researchers at the Tufts-New England Me... appearing in the May/June issue of Health Affairs...
Other Medicine News:Health News:Dabur India Q4 Profit Surges 31% 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 3Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 4Health News:Health Authorities Fear West Nile Season Again in US 2Health News:Drug Risks Must Be Balanced Against Benefits, Researchers 2
(Date:10/13/2008)....5 million dollar NIH funding advances study ...al rates, MINNEAPOLIS, Oct. 13 /- Ad...ncedcirculatory.com ) announced today that it has ...m the National Institutes of,Health (NIH) to conti...n on,those who experience cardiac arrest outside a...
(Date:10/13/2008)... Announce Interim Results in January 2009 and Fina... -, EMERYVILLE, Calif., Oct. 13 /PRNewswire-First...)) (Nasdaq: NTII ) today announced that following...ion to discuss the,Viprinex(TM) (ancrod) Phase 3 c...pany plans to consolidate and analyze data from it...
(Date:10/12/2008)...and WASHINGTON, Oct. 12 /- ...announced results from an analysis,of nearly 7,500..., which,are designed to confirm the performance of...nary Stent System in real-world practice. The,two-...t reduced clinical,restenosis in patients with dia...
(Date:10/10/2008)... Oct. 10 /- Boston Scientif...chedule of the Company,s major,events and press an...ion,s,(CRF) twentieth annual Transcatheter Cardiov...hich runs from October 12 to 17 in Washington, D.C...nge of safety and,efficacy data on its TAXUS(R) Ex...
Breaking Medicine Technology:Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 1Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 2Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 3The Gender Divide Starts Over Dinner 14720 1The Gender Divide Starts Over Dinner 14720 2The Gender Divide Starts Over Dinner 14720 3Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 1Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 2Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 3Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 4American Transplant Congress 2008 Critical New Data to be Revealed in Toronto 14718 1American Transplant Congress 2008 Critical New Data to be Revealed in Toronto 14718 2
... Alequel(TM), an,individualized oral immune regula...r moderate-to-severe Crohn,s disease. Interim,data... Phase II,studies suggest that this investigationa...proved patients, quality of life compared,to place...assah,Medical Center, Jerusalem, Israel, will toda...
...Patient Populations,Studied of Any Drug-Eluting St..., Calif., May 22, 2007,/PRNewswire-FirstCall/ -- X...data from the CUSTOM II clinical trial, which asse...stigational Custom,NX(R) drug-eluting stent (DES) ...ons in patients with coronary artery disease. , Th...
Other Medicine Technology:Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 2Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 2XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 4
ICDMeister is an electronic reference containing 15,000 of the 2006 ICD-9-CM diagnosis codes. Use whichever of the four different approaches for finding codes that you .
... (Palm OS) makes the patient appointment, the char...lity of the MedPlexus System accessible through a... access to data that was previously available only...reate super bills and more. The information stored...
MD Coder v 6.0 is a charge capture for the Palm OS and Pocket PC operating systems. We have integrated the feedback from hospitals and physicians. MD Coder v 6.0 comes in three versions: Physician Ba
A Palm Pilot and Desktop utility that you can use. Search for ICD codes in your office on your computer or in the field using your Palm Pilot.
Medicine Products: